Table 2. Factors contributing to the attenuation of microvascular obstruction.
Hypothetical factor | Species | Experimental model | Effect | Ref. |
CAO: coronary artery occlusion; CBF: coronary blood flow; eNOS: endothelial NO-synthase; MVO: microvascular obstruction; NO: nitric oxide; PKA: protein kinase A; | ||||
Na+/H+ exchanger | Rabbit | CAO and reperfusion in vivo | Cariporide reduced infarct size and the no-reflow area | [60] |
Nitric oxide | Pig | CAO and reperfusion in vivo | NO inhalation resulted in a decrease in infarct size. NO inhalation increased CBF in the area at risk | [61] |
Adenosine | Dog | CAO and reperfusion in vivo | Adenosine reduced infarct size by decreasing the release of endothelin from the heart during I/R | [65] |
Dog | CAO and reperfusion in vivo | Infusion of adenosine during the first hour of reperfusion mitigated MVO | [43] | |
Dog | CAO and reperfusion in vivo | Adenosine increased CBF in the subendocardium with no change in CBF in the midmyocardium and epicardium | [65] | |
Rabbit | CAO and reperfusion in vivo | Adenosine had no effect on MVO | [55] | |
Minipig | CAO and reperfusion in vivo | Adenosine reduced the no-reflow area by 75% | [57] | |
Rabbit | CAO and reperfusion in vivo | GP531 had no effect on CBF in the area at risk in reperfusion | [67] | |
Pig | CAO and reperfusion in vivo | It was found that adenosine reduced the no-reflow area by 47% | [68] | |
Kinases and NO-synthase | Rat | CAO and reperfusion in vivo | Tongxinluo reduced the no-reflow area by 80%. Tongxinluo promoted phosphorylation of eNOS and increased PKA activity |
[69] |
Minipig | CAO and reperfusion in vivo | Simvastatin reduced the no-reflow area by 28%. eNOS is involved in this effect of simvastatin | [71] | |
KATP channels | Minipig | CAO and reperfusion in vivo | The KATP channel opener and an NO donor nicorandil reduced infarct size and the no-reflow area | [74–75] |
Ischemic conditioning | Rabbit | CAO and reperfusion in vivo | Ischemic preconditioning decreased the no-reflow area by 37% | [60] |
Minipig | CAO and reperfusion in vivo | Ischemic preconditioning reduced the MVO area by 78%. PKA and eNOS are involved in this effect | [70] | |
Minipig | CAO and reperfusion in vivo | Remote preconditioning reduced infarct size by 24%, and the no-reflow area by 45% | [76] | |
Rabbit | CAO and reperfusion in vivo | Post-conditioning had no effect on infarct size and the no-flow | [77] | |
Pig | CAO and reperfusion in vivo | Ischemic post-conditioning had no effect on infarct size or the MVO area |
[78] |
|
Pig | CAO and reperfusion in vivo | Ischemic pre-conditioning reduced infarct size by 50% and the MVO area by 80%. Post-conditioning had no effect on infarct size and the MVO area | [79] | |
Pig | CAO and reperfusion in vivo | Ischemic pre-conditioning, ischemic post-conditioning, and remote perconditioning decreased myocardial edema and the MVO area | [80] |